Hunter Shkolnik Discusses Teva’s $23 Billion Offer

November 7, 2019

Source: Legal Reader

Teva Pharmaceutical Industries Ltd.’s proposed $23 billion drug giveaway over it’s suggesting to settle the opioid lawsuits against it will likely cost the company a fraction of that figure, according to industry experts. When Teva announced the value of the donated medicine – a generic version of opioid addiction treatment Suboxone – it based the figure on the drug’s list price, which does not account for significant discounts it will receive.

Share This: